Global Coverage / One Network
Manufacturing geography should expand the solution space.
CDMO Network™ connects biotechnology and pharmaceutical programmes with manufacturing capabilities across major global biomanufacturing regions. The objective is not to force a programme into one geography, one facility, or one predefined vendor path.
We begin with the programme — modality, stage, process, quality level, scale, timing, technical constraints, and commercial requirements — then map the manufacturing route around it.
The full partner network is not published publicly. Introductions are made after initial scoping so conversations remain relevant, confidential, and technically useful.
We route programmes across five connected dimensions.
What is being manufactured?
Where is the programme in development?
What technical work must actually be done?
Where can the programme execute effectively?
What makes this particular programme difficult?
The Global Manufacturing Ecosystem
One network. Different regional strengths.
Biomanufacturing capability is distributed. Capacity changes. Regulatory frameworks differ. Supply chains cross borders. CDMO Network™ treats geography as one component of manufacturing fit rather than as the starting assumption.
North America
A major centre for sponsor-led development, clinical manufacturing, advanced therapeutics, biologics, analytical programmes, and commercial supply.
- Development-intensive and early clinical programmes
- High sponsor interaction and technical collaboration
- Biologics, advanced therapies, drug product and analytical support
Europe
A dense network of specialised manufacturing ecosystems, mature quality systems, cross-border technical expertise, and development-to-commercial infrastructure.
- Biologics, viral vectors, vaccines, sterile DP and specialised platforms
- Cross-border manufacturing and technology-transfer strategies
- Clinical and commercial programmes requiring European execution
India & South Asia
A large and expanding life-science manufacturing ecosystem with broad technical infrastructure, scalable operations, and important global supply-chain roles.
- Scale-sensitive manufacturing strategies
- Microbial, biologics, pharmaceutical and analytical capabilities
- Global programme support and supply integration
East & Southeast Asia
High-capability manufacturing clusters across major Asian biotechnology markets provide specialised platforms, additional capacity, and geographic diversification.
- Specialised biologics and biotechnology capacity
- Regional and global supply strategies
- Manufacturing redundancy and geographic diversification
Latin America
Regional biotechnology and pharmaceutical manufacturing ecosystems can support targeted programmes, local supply, vaccines, biologics, fill-finish, and market-specific execution.
- Regional supply and market-access strategies
- Biologics, vaccines and selected GMP manufacturing
- Brazil and other emerging manufacturing hubs
Middle East & North Africa
Growing pharmaceutical, vaccine, animal-health, fill-finish, and regional manufacturing infrastructure is creating new options for programmes serving MENA markets.
- Regional manufacturing and technology-transfer strategies
- Vaccines, pharmaceutical supply and animal-health programmes
- Market-specific partnerships and developing infrastructure
The Network Model
Capability before facility.
The right manufacturing path may sit inside one organisation, or it may require several specialised partners. CDMO Network™ begins with what the programme needs and structures the route around technical fit, timing, geography, quality, and execution.
Programme
Modality, stage, scale, scope, quality level, timeline, geography and critical constraints.
Capability
Translate the requirement into actual technical and operational manufacturing capabilities.
Partners
Identify realistic paths across the Network rather than distributing a generic vendor list.
Conversation
Carry programme context into introductions, technical review, RFQ development, quoting and next steps.
Request A Match
Start with the programme.
Send the modality, development stage, manufacturing scope, approximate scale, timing, preferred geography, and any technical constraints. We use that information to define realistic manufacturing routes and relevant partner options.
Share the programme and the manufacturing need.
Clarify technical, commercial and geographic constraints.
Identify realistic capability and partner routes.
Coordinate high-signal introductions and next steps.
Manufacturing belongs in an ecosystem.
CDMOs and specialist manufacturing organisations can contact CDMO Network™ regarding network participation and programme routing.